Back
Allogene Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
ALLO
Allogene Therapeutics, Inc.
Last Price:
$2.48
Seasonality Move:
-2.82%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.
Allogene Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Buy |
| 20-day SMA: | 2.38 | Buy |
| 50-day SMA: | 2.14 | Buy |
| 200-day SMA: | 1.5 | Buy |
| 8-day EMA: | 2.35 | Buy |
| 20-day EMA: | 1.88 | Buy |
| 50-day EMA: | 1.11 | Buy |
| 200-day EMA: | 0.35 | Buy |
Allogene Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 54.9 | Buy |
| Chaikin Money Flow: | -3067599 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.59) | Buy |
| Bollinger Bands (100): | (1.3 - 2.24) | Buy |
Allogene Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics, Inc. Stock
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 2.48 while ALLO 8-day simple moving average is 2.36, which is a Buy signal.
-
The stock price of ALLO is 2.48 while Allogene Therapeutics, Inc. 20-day SMA is 2.38, which makes it a Buy.
-
Allogene Therapeutics, Inc. 50-day simple moving average is 2.14 while ALLO share price is 2.48, making it a Buy technically.
-
ALLO stock price is 2.48 and Allogene Therapeutics, Inc. 200-day simple moving average is 1.50, creating a Buy signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
31
Allogene Therapeutics, Inc. (ALLO)
is a Sell
Is Allogene Therapeutics, Inc. a Buy or a Sell?
-
Allogene Therapeutics, Inc. stock is rated a SellThe current Allogene Therapeutics, Inc. [ALLO] share price is $2.48. The Score for ALLO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics, Inc. Stock Info
Market Cap:
585.7M
Price in USD:
2.48
Share Volume:
4.3M
Allogene Therapeutics, Inc. 52-Week Range
52-Week High:
2.80
52-Week Low:
0.86
Sell
31
Allogene Therapeutics, Inc. (ALLO)
is a Sell
Allogene Therapeutics, Inc. Share Price Forecast
-
What is the Allogene Therapeutics, Inc. stock price today?The Allogene Therapeutics, Inc. stock price is 2.48 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics, Inc. is overvalued.
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 2.48 while ALLO 8-day exponential moving average is 2.35, which is a Buy signal.
-
The stock price of ALLO is 2.48 while Allogene Therapeutics, Inc. 20-day EMA is 1.88, which makes it a Buy.
-
Allogene Therapeutics, Inc. 50-day exponential moving average is 1.11 while ALLO share price is 2.48, making it a Buy technically.
-
ALLO stock price is 2.48 and Allogene Therapeutics, Inc. 200-day simple moving average is 0.35, creating a Buy signal.
Fundamental Analysis of Allogene Therapeutics, Inc.
Is Allogene Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Allogene Therapeutics, Inc.
Should I short Allogene Therapeutics, Inc. stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is 0.55, suggesting Allogene Therapeutics, Inc. is a Buy
-
Allogene Therapeutics, Inc. Relative Strength Index (RSI) is 54.9, which suggest Allogene Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Allogene Therapeutics, Inc. is (2.23 - 2.59), which suggest Allogene Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Allogene Therapeutics, Inc. is (1.3 - 2.24), which suggest Allogene Therapeutics, Inc. is a Buy
* Allogene Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.